A 2014 study out of Sweden, titled “Use of Ondansetron During Pregnancy and Congenital Malformations in the Infant,” investigated the risks associated with taking the anti-nausea medication Zofran (ondansetron) during a woman’s pregnancy. The study was conducted using data from the Swedish Medical Birth Register and from the Swedish Register of Prescribed Drugs, examining 1,349 infants …. Read More
Did You Take Zofran During Your First Trimester?
Was Your Baby Born With Cleft Palate
or a Congenital Heart Defect?
Two mothers have filed product liability lawsuits against drug giant GlaxoSmithKline in mid-February 2015, both alleging that the anti-nausea medication Zofran (ondansetron), which they both took during their respective pregnancies to combat morning sickness, was to blame for the severe birth defects their children developed. Approved by the FDA for prescription to patients experiencing nausea …. Read More
A study published by the American Journal of Obstetrics and Gynecology in December 2014 sheds a bright light on the risks pregnant women face if they choose to take the popular anti-nausea medication Zofran (ondansetron) to help ease their morning sickness symptoms. Dr. Gideon Koren, affiliated with The Motherisk Program, The Hospital for Sick Children, and …. Read More
Heart risks associated with the use of anti-nausea medication Zofran (ondansetron) by pregnant mothers aren’t solely limited to unborn babies − infants and small children remain at risk for potentially fatal heart-related side effects of Zofran as well. According to the findings of a study published in the journal Pediatric Emergency Care, prescribing Zofran for nausea …. Read More
GlaxoSmithKline’s powerful anti-nausea medication Zofran, approved only for patients undergoing chemotherapy or recovering from surgery, has been prescribed in an off-label manner by doctors to pregnant women to alleviate morning sickness symptoms—but at an enormous price. Concern is mounting over the increased number of prescriptions doctors are writing for expectant mothers, and whether or not …. Read More